Kevin Chung

ORCID: 0000-0003-0402-6833
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA and protein synthesis mechanisms
  • RNA Research and Splicing
  • RNA modifications and cancer
  • Airway Management and Intubation Techniques
  • Advanced Electron Microscopy Techniques and Applications
  • Anesthesia and Sedative Agents
  • Synthesis and Reactions of Organic Compounds
  • Organic Chemistry Cycloaddition Reactions
  • Bacteriophages and microbial interactions
  • Synthesis and Characterization of Heterocyclic Compounds
  • Force Microscopy Techniques and Applications
  • Chromosomal and Genetic Variations
  • Electron and X-Ray Spectroscopy Techniques
  • Advanced biosensing and bioanalysis techniques
  • Cardiac, Anesthesia and Surgical Outcomes

Yale University
1992-2025

Abstract The group II intron ribonucleoprotein is an archetypal splicing system with numerous mechanistic parallels to the spliceosome, including excision of lariat introns 1,2 . Despite importance branching in RNA metabolism, structural understanding this process has remained elusive. Here we present a comprehensive analysis three single-particle cryogenic electron microscopy structures captured along pathway. They reveal network molecular interactions that specifies branchpoint adenosine...

10.1038/s41586-023-06746-6 article EN cc-by Nature 2023-11-22

Group II introns are ribozymes that catalyze their self-excision and function as retroelements invade DNA. As retrotransposons, group form ribonucleoprotein (RNP) complexes roam the genome, integrating by reversal of forward splicing. Here we show retrotransposition is achieved a tertiary complex between structurally elaborate ribozyme, its protein mobility factor, structured DNA substrate. We solved cryo–electron microscopy structures an intact IIC intron-maturase retroelement was poised...

10.1126/science.abq2844 article EN Science 2022-11-10

Targeting RNA with small molecules has emerged as a promising approach in drug development, offering the potential to expand druggable genome and enable pharmacological targeting of non-coding genes or difficult-to-target gene products. However, identification functionally active binders faces low hit rates routine chemical space exploration lacks robust high-throughput screening assays. The visualization atomic details RNA-small molecule interactions also poses challenge due dynamic nature...

10.1063/4.0000350 article EN cc-by Structural Dynamics 2025-03-01

Despite the promise of vastly expanding druggable genome, rational design RNA-targeting ligands remains challenging as it requires rapid identification hits and visualization resulting cocomplexes for guiding optimization. Here, we leveraged high-throughput screening, medicinal chemistry, structural biology to identify a de novo splicing inhibitor against large highly folded fungal group I intron. High-resolution cryoEM structures intron in different liganded states not only reveal molecular...

10.1073/pnas.2502425122 article EN cc-by Proceedings of the National Academy of Sciences 2025-05-08
Coming Soon ...